Coronary Artery Disease Does Not Increase Risk of Cardiovascular Events and Mortality One Year After Liver Transplantation.
作者信息
Biolato Marco, Avolio Alfonso W, Miele Luca, Marrone Giuseppe, Agnes Salvatore, Pompili Maurizio
机构信息
Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome 00168, Italy.
Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, Rome 00168, Italy.
出版信息
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102412. doi: 10.1016/j.jceh.2024.102412. Epub 2024 Sep 19.
Abstract
摘要
相似文献
1
Coronary Artery Disease Does Not Increase Risk of Cardiovascular Events and Mortality One Year After Liver Transplantation.冠状动脉疾病不会增加肝移植术后一年内心血管事件和死亡的风险。
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102412. doi: 10.1016/j.jceh.2024.102412. Epub 2024 Sep 19.
2
3
Exercise interventions for adults after liver transplantation.肝移植术后成人的运动干预措施。
Cochrane Database Syst Rev. 2023 May 19;5(5):CD013204. doi: 10.1002/14651858.CD013204.pub2.
4
Safety, efficacy, and outcomes of invasive coronary angiography in liver transplant candidates.肝移植候选者行有创冠状动脉造影的安全性、有效性及结果
JHEP Rep. 2025 Apr 22;7(7):101428. doi: 10.1016/j.jhepr.2025.101428. eCollection 2025 Jul.
5
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.体重与冠状动脉疾病的全因死亡率及心血管事件的关联：队列研究的系统评价
Lancet. 2006 Aug 19;368(9536):666-78. doi: 10.1016/S0140-6736(06)69251-9.
6
Higher blood pressure targets for hypertension in older adults.老年人高血压的更高血压目标
Cochrane Database Syst Rev. 2024 Dec 17;12(12):CD011575. doi: 10.1002/14651858.CD011575.pub3.
7
Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta-analysis.持续气道正压通气治疗对合并阻塞性睡眠呼吸暂停的冠心病患者有益吗？系统评价和荟萃分析。
Clin Cardiol. 2021 Aug;44(8):1041-1049. doi: 10.1002/clc.23669. Epub 2021 Jun 19.
8
Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: A systematic review and meta-analysis.经皮冠状动脉介入治疗后冠心病患者临床结局的性别差异：一项系统评价和荟萃分析。
Medicine (Baltimore). 2018 Jul;97(30):e11644. doi: 10.1097/MD.0000000000011644.
9
Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.基因预测的脂蛋白(a)与冠状动脉斑块严重程度相关，独立于低密度脂蛋白胆固醇。
Eur J Prev Cardiol. 2025 Jan 27;32(2):116-127. doi: 10.1093/eurjpc/zwae271.
10
Antioxidants for chronic kidney disease.用于慢性肾病的抗氧化剂。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2.
本文引用的文献
1
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.肝移植治疗非酒精性脂肪性肝病肝硬化：年龄和近期冠状动脉成形术是生存的主要决定因素。
Liver Int. 2022 Nov;42(11):2428-2441. doi: 10.1111/liv.15385. Epub 2022 Aug 25.
2
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9.
3
A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.原位肝移植心血管风险的基于点的预测模型：CAR-OLT评分。
Hepatology. 2017 Dec;66(6):1968-1979. doi: 10.1002/hep.29329. Epub 2017 Nov 6.
4
Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.接受冠状动脉血运重建的肝移植受者的结局：有和没有心血管危险因素的比较分析
Transplantation. 2017 Apr;101(4):793-803. doi: 10.1097/TP.0000000000001647.
5
Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study.经血管造影证实的冠状动脉疾病患者的肝移植结果：一项多机构研究。
Am J Transplant. 2013 Jan;13(1):184-91. doi: 10.1111/j.1600-6143.2012.04293.x. Epub 2012 Nov 5.
Zotero 插件